{"name":"Highlight Therapeutics","slug":"highlight-therapeutics","ticker":"","exchange":"","domain":"highlight.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOaGZpc2lURHBrWG80eGYtS1RPLThVQmZOWW5aajlyTnpsLTNyM2RWUDJLWUJyRVZBRmxKN0tseEtEc1ZORWNtNVRtQzZrWXBkVjNtME1TUkRUaXJZVU91M1FNOS1IeDd5ZTJKbmh4ZUs1a1d4ZW9tdU04RzZNNzFlOWNPRDZMai1NWFB5bzVGQm9pVmJ6VlRYZ1Zvc0NwMF9IcnBFY3IxUWF1c3hYMS1GTw?oc=5","date":"2026-04-06","type":"pipeline","source":"Yahoo Finance","summary":"Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics - Yahoo Finance","headline":"Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Ther","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNS05IbnFMNEVHSTdxNkd5aXk1OU5aNU1uM2FDQ0daY29EcGdPdUlDZGhPLTFrNmxIRzl6RF9IcGc0TElQMFg0ZE9XN05GQTNCVjd3NjdTeHRmd2lPelBhdnNnQ1JZdjEyWlNCTzBfQUNMNEJWN1ZwRzFWaWVhejNXRVBZWWZfMThZbzlPU3V2ZTFaVFFPQm40bHJ4TktzUmR4ajRjWmt4TktEWVRVdGlFNlF4Y2hiWGVaaTVuakJSbnp0Ry1jN3A2UTRBWDdENGtueGFUSmpxUUg1Z0pkSGJaUmJNUmJBZXM?oc=5","date":"2026-02-11","type":"trial","source":"Proactive financial news","summary":"Candel Therapeutics to highlight glioblastoma immunotherapy data at Boston summit | NASDAQ:CADL - Proactive financial news","headline":"Candel Therapeutics to highlight glioblastoma immunotherapy data at Boston summit | NASDAQ:CADL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxOQTR0d1l3a3B2VmdFdjY0QkJVZ01rYmtPV0gtNERtMXMyN1lXdTdpOTFRRjFjREFaSENvbDByU2JUdzRVZ2Mxc3dsbU8zYm5MUElhVGl3RHkyU3NzaTZ5b3U2T1NOUGlUaE90MDNtUTB1Z2xIeWRSZ1NfTEpwU1hzcDZiZnpYX0puU1lTZmYyMDZ6YS02YnowdU1jbU1wZmh0d3pYNmpiYV9VVnpzTXRva09wdE9RUzZ1d3dWOGtVMGJwVmFaVkJndlJMM09oSWRhUWZKVUJJSW1iSXBWc0p5bm83ZlZOYmxaZXdEOG1ZZHZib2pxcUltWmFrdjJha0JhRFNKYTF3QlFjd0hEN29VTVJB?oc=5","date":"2026-02-04","type":"trial","source":"PR Newswire","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - PR Newswire","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQaHNyZWtjVnNRZzctdWE4VDVqNFRlR3oxSE05eGF0ZTB5aUFOTjhNYXc5VDJsUU9ib3NVZ2ozREpDWjhkUnpKZmhGQklhNXNGaUpUN0dwclFIY1kxS1l6bHRaaDh2Q3Q3ZmNtc2dJNnJoT1pIeGNGcVZ5U3BfMmV1VnBxeldPTnF0RWFQVXZuQQ?oc=5","date":"2026-01-08","type":"pipeline","source":"Yahoo Finance","summary":"Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance","headline":"Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceutic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQV3NWekFINnp3alNCUUY1SUZrUGdEb1FrbXpmcEFyRUZ5TC03ZU92cUQtQm9hdHoxajlicVlwT3k2b1pMQW1xLXV6Q0hVa0stOVNfWG5fUEk4S052dFdGQTFQeXVfVEsybHU5UkNQbjM5cElDenRmMFF0VFNEVTVTZ2RzT3BpUURZUWFtTUdhWVRDdFVaVEhOWHRxZ2VKQQ?oc=5","date":"2025-12-01","type":"deal","source":"Fierce Pharma","summary":"PODD: Partnership Opportunities in Drug Delivery 2025 Recap - Fierce Pharma","headline":"PODD: Partnership Opportunities in Drug Delivery 2025 Recap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPZFpHOFBRMERVODBYMHR1b1U1TmdIWVZFNFE3MmJqdF8wUGR5UXZPb3NyOGZHWml4cXZ4d3lxWEp3WExIbXJJOWhvaGhNeFdRNC1LOU1CMFZGVnkwaDZGeTZjckNoZXRtS1pNZGhOTnNiU0dSTXA4ZHg2UTQ0NFpEVS02WHpUeGx3Y1pBNjhQMlpnckJQczRkQUFmQ21aODF6RFNuWGgwdUZSSV9CcWF4d1dlQXVPMjNuN3BEOWs3UmFKZ2lZai1GaVVDbVhKa1RBbmxkTWlYQXRUQTBUT084V3IzOW1MOWE1dUpn?oc=5","date":"2025-11-06","type":"earnings","source":"Business Wire","summary":"Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress - Business Wire","headline":"Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxQNFNjdDVOY1g4TUhaWFo0WDdoMTlVT2JfZU5hb19FakxVc1lQRlNMa2xHanZxdGptYk95NU9NdWtxM01NMkxEQnhCWWNUbXk2TjA0UE1WZlRKR2xFbDcwRVBZNlNLazhnUkRKRDcxVmlVQ0U0NHNONnhOVVRXXzVqNC1UbTM1dklMYjVGQkVtNDVEVEF6bEtQOC1Pd2p5NnJkU3N0OWdOcUJJY09JcVB5bkNrWnhrUUlZZDRfUGhkaUNsd0R1Z1Z5XzJJaWxIbjVHUzc3TnpHZUJ0ZW1IOWJfOHBTVnY1WHh6T2gyaVlXb1JTdjVSbUtrM1oyN0RxTXl5dzJ2MVhKeUs3Tk1iWFNDOVQzVDlMbFhTRldqM0l2Tk00TW94RWhUUWZoZjM3b0RINHpZdDlpZVVDdm0y?oc=5","date":"2025-10-23","type":"trial","source":"Business Wire","summary":"Circle Pharma Unveils First Preclinical Data from Cyclin D1 Program at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Business Wire","headline":"Circle Pharma Unveils First Preclinical Data from Cyclin D1 Program at the AACR-NCI-EORTC International Conference on Mo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPekdqd0ZLQ3J3NXdXcHQ0NnFTR2ViQ0pyZEZaakVleWMtTVBhb0RuM1VCR2thT0pzb2xDZS1iQXpIWjg4S0tZVThMSmFCdndERG81VU1VMDVxZjMycmlSV1ZTTkV5bWhyY2JtZ2htSV9uNWpiX040SkFpWnFKN1RmWUtmT29qUFhJ?oc=5","date":"2025-09-10","type":"trial","source":"Yahoo Finance","summary":"Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Yahoo Finance","headline":"Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Ent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQZEFqalBHaXJoQ2ljNm1qcHd5QVlzeEsxYmd6bmRUNnR6Y2Izejk1SUpGV2xCTzVLUlNPMlUyNlctTEQ0bmFYRXJvN3A5bmN2UnFfOU96cWJqLWswTVUwUjJjQWNvb1Z5Z3NmVk52ZEhuM1RrcWY2ZGdfYTlhY2NKVGxVdUNJcUhqV1dUWk1ucGVDUGEwajg1OENhS3lDLVh6aEVkSGhaRnY1VlA2QzMzdjJZYw?oc=5","date":"2025-08-23","type":"pipeline","source":"Contract Pharma","summary":"Energenesis Highlights Investigational Parkinson’s Disease Therapy - Contract Pharma","headline":"Energenesis Highlights Investigational Parkinson’s Disease Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE1qY0F2OXdFT1BaWkYtRFRnamdaNkpWZ0FFYXRZdzQxU0tSTnJKWkplU1NkX29hTEFQQWJPY0VVV2hheWUyVVF4VXNHZ0VHWlJJQzAzc2RCMTRDOUJlZHF0MXEwTWRQUFpheVNwSmlhcw?oc=5","date":"2025-08-19","type":"pipeline","source":"Labiotech.eu","summary":"Meet 10 biotech companies you can’t miss in Spain in 2025 - Labiotech.eu","headline":"Meet 10 biotech companies you can’t miss in Spain in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxNOW5sNm1sWnc2QlV2SEFsNFBpSFlSajlOTDVTcDFZQTMyZjZ1VkVNb01PWXpMeFBZczA5Z2RReDM2X3ZTMk80RGhwVjdya2taRXBoNFlQaVNpMzVYZjI4S3o0YUVMVGZpajlFUENYOC01c1RoV09teVFYU3VuYjZ4WnpIWThIa00zMzRGajZjQTJweWJOMk1YODE2Q0VlN1FhNGVjcXdoRGRXY3pJeF80Znl3cER2QzlkelhRRDBDYTNPUFlmaDhYWk1SdlgzQVNxQ2dwSVV5dEF1dEZZWUpLeXV6cWtmZmxXRE11UUhsWU9FczZkdWpBUTg4SmJGajItRmloT2pOSQ?oc=5","date":"2025-04-25","type":"trial","source":"BioSpace","summary":"Onchilles Pharma Presents New Data at AACR 2025 Highlighting N17350, a Next-Generation Cytotoxic Therapeutic Leveraging the ELANE Pathway - BioSpace","headline":"Onchilles Pharma Presents New Data at AACR 2025 Highlighting N17350, a Next-Generation Cytotoxic Therapeutic Leveraging ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPOUJQODhRejdCTWI2eVRtTHpobUhhQ1VMYnNUM0ZQUDZ0OUh4YXc3LU1uc3NsYkJKem54TXEzOGd6M2JRcFZHTThPTjlma1d6OHJVN1BYQkJjUkJWNWJVUm9VZ3RPS2I3cjBrbzZBallUS0hCM2hmRTdrVzlGcGtXQXpPY1hHQQ?oc=5","date":"2024-05-13","type":"pipeline","source":"Montefiore Einstein Now","summary":"Leading Scientists Highlight Therapeutics Advancements at Montefiore Einstein Comprehensive Cancer Center’s First Drug Development Symposium - Montefiore Einstein Now","headline":"Leading Scientists Highlight Therapeutics Advancements at Montefiore Einstein Comprehensive Cancer Center’s First Drug D","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}